Research synthesisModerate evidenceSmall effect9 studies · 9 beneficial · 0 neutral · 0 harmful
Across 9 studies, all reported beneficial effects for reduced inflammation, with predominantly small effect sizes. Evidence includes a meta-analysis and a systematic review, but only one study reached statistical significance. Most studies assessed general probiotic interventions rather than specifically Lactobacillus acidophilus L-92, limiting direct applicability.
- Studied populations: subjects with type 2 diabetes, underweight individuals, individuals with environmental sensitivity illnesses (fibromyalgia, chronic fatigue syndrome, multiple chemical sensitivity), older adults with sarcopenia or obesity, athletes
Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Only 1 of 9 studies reported statistically significant findings, suggesting the true effect may be smaller or less consistent. Most studies are reviews or meta-analyses of broader probiotic strains rather than direct trials of Lactobacillus acidophilus L-92, so causation cannot be attributed to this specific strain. No dose or form data were reported, and study durations were inconsistently reported.
Generated Jul 11, 2026